Cardio Diagnostics Holdings

Cardio Diagnostics Holdings

Biotechnology, 400 N Aberdeen St Ste 900, Chicago, Illinois, 60642, United States, 1-10 Employees

cardiodiagnosticsinc.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 85********

Who is CARDIO DIAGNOSTICS HOLDINGS

Cardio Diagnostics is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The Company was formed to furthe...

Read More

map
  • 400 N Aberdeen St Ste 900, Chicago, Illinois, 60642, United States Headquarters: 400 N Aberdeen St Ste 900, Chicago, Illinois, 60642, United States
  • 2017 Date Founded: 2017
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2835 | NAICS Code: 325413 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from CARDIO DIAGNOSTICS HOLDINGS

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Cardio Diagnostics Holdings

Answer: Cardio Diagnostics Holdings's headquarters are located at 400 N Aberdeen St Ste 900, Chicago, Illinois, 60642, United States

Answer: Cardio Diagnostics Holdings's phone number is 85********

Answer: Cardio Diagnostics Holdings's official website is https://cardiodiagnosticsinc.com

Answer: Cardio Diagnostics Holdings's revenue is $1 Million to $5 Million

Answer: Cardio Diagnostics Holdings's SIC: 2835

Answer: Cardio Diagnostics Holdings's NAICS: 325413

Answer: Cardio Diagnostics Holdings has 1-10 employees

Answer: Cardio Diagnostics Holdings is in Biotechnology

Answer: Cardio Diagnostics Holdings contact info: Phone number: 85******** Website: https://cardiodiagnosticsinc.com

Answer: Cardio Diagnostics is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The Company was formed to further develop and commercialize a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic EngineTM (Core Technology) for cardiovascular disease to become one of the leading medical technology companies for enabling improved prevention, early detection, and assists in the treatment of cardiovascular disease.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access